Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

43 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
FDG-PET-CT reduces the interobserver variability in rectal tumor delineation.
Buijsen J, van den Bogaard J, van der Weide H, Engelsman S, van Stiphout R, Janssen M, Beets G, Beets-Tan R, Lambin P, Lammering G. Buijsen J, et al. Among authors: van stiphout r, van den bogaard j, van der weide h. Radiother Oncol. 2012 Mar;102(3):371-6. doi: 10.1016/j.radonc.2011.12.016. Epub 2012 Jan 24. Radiother Oncol. 2012. PMID: 22280807
Tumor volume combined with number of positive lymph node stations is a more important prognostic factor than TNM stage for survival of non-small-cell lung cancer patients treated with (chemo)radiotherapy.
Dehing-Oberije C, De Ruysscher D, van der Weide H, Hochstenbag M, Bootsma G, Geraedts W, Pitz C, Simons J, Teule J, Rahmy A, Thimister P, Steck H, Lambin P. Dehing-Oberije C, et al. Among authors: van der weide h. Int J Radiat Oncol Biol Phys. 2008 Mar 15;70(4):1039-44. doi: 10.1016/j.ijrobp.2007.07.2323. Epub 2007 Sep 24. Int J Radiat Oncol Biol Phys. 2008. PMID: 17889446
Development and external validation of prognostic model for 2-year survival of non-small-cell lung cancer patients treated with chemoradiotherapy.
Dehing-Oberije C, Yu S, De Ruysscher D, Meersschout S, Van Beek K, Lievens Y, Van Meerbeeck J, De Neve W, Rao B, van der Weide H, Lambin P. Dehing-Oberije C, et al. Among authors: van meerbeeck j, van der weide h, van beek k. Int J Radiat Oncol Biol Phys. 2009 Jun 1;74(2):355-62. doi: 10.1016/j.ijrobp.2008.08.052. Epub 2008 Dec 25. Int J Radiat Oncol Biol Phys. 2009. PMID: 19095367
Development and validation of a prognostic model using blood biomarker information for prediction of survival of non-small-cell lung cancer patients treated with combined chemotherapy and radiation or radiotherapy alone (NCT00181519, NCT00573040, and NCT00572325).
Dehing-Oberije C, Aerts H, Yu S, De Ruysscher D, Menheere P, Hilvo M, van der Weide H, Rao B, Lambin P. Dehing-Oberije C, et al. Among authors: van der weide h. Int J Radiat Oncol Biol Phys. 2011 Oct 1;81(2):360-8. doi: 10.1016/j.ijrobp.2010.06.011. Epub 2010 Oct 1. Int J Radiat Oncol Biol Phys. 2011. PMID: 20888135
Proton therapy for selected low grade glioma patients in the Netherlands.
van der Weide HL, Kramer MCA, Scandurra D, Eekers DBP, Klaver YLB, Wiggenraad RGJ, Méndez Romero A, Coremans IEM, Boersma L, van Vulpen M, Langendijk JA; Dutch Society for Radiation Oncology NVRO. van der Weide HL, et al. Radiother Oncol. 2021 Jan;154:283-290. doi: 10.1016/j.radonc.2020.11.004. Epub 2020 Nov 14. Radiother Oncol. 2021. PMID: 33197495 Free article. Review.
Evaluating and reporting LET and RBE-weighted dose in proton therapy for glioma - The Dutch approach.
Wagenaar D, Habraken SJM, Rinaldi I, Eekers DBP, Kramer M, Jaspers JPM, van Gent D, Barazzuol L, Klaver YLB, Zindler J, Coremans I, Compter I, Scandurra D, van der Weide HL, Both S, Hoogeman M, Unipan M, Méndez Romero A. Wagenaar D, et al. Among authors: van der weide hl. Radiother Oncol. 2025 Jan;202:110653. doi: 10.1016/j.radonc.2024.110653. Epub 2024 Nov 26. Radiother Oncol. 2025. PMID: 39603511 Free article.
The European Particle Therapy Network (EPTN) consensus on the follow-up of adult patients with brain and skull base tumours treated with photon or proton irradiation.
De Roeck L, van der Weide HL, Eekers DBP, Kramer MC, Alapetite C, Blomstrand M, Burnet NG, Calugaru V, Coremans IEM, Di Perri D, Harrabi S, Iannalfi A, Klaver YLB, Langendijk JA, Romero AM, Paulsen F, Roelofs E, de Ruysscher D, Timmermann B, Vitek P, Weber DC, Whitfield GA, Nyström PW, Zindler J, Troost EGC, Lambrecht M; work package 1 of the taskforce “European Particle Therapy Network” of ESTRO. De Roeck L, et al. Radiother Oncol. 2022 Mar;168:241-249. doi: 10.1016/j.radonc.2022.01.018. Epub 2022 Jan 29. Radiother Oncol. 2022. PMID: 35093408 Review.
Review - Late toxicity of abdominal and pelvic radiotherapy for childhood cancer.
Hessels AC, Langendijk JA, Gawryszuk A, Heersters MAAM, van der Salm NLM, Tissing WJE, van der Weide HL, Maduro JH. Hessels AC, et al. Among authors: van der salm nlm, van der weide hl. Radiother Oncol. 2022 May;170:27-36. doi: 10.1016/j.radonc.2022.02.029. Epub 2022 Mar 4. Radiother Oncol. 2022. PMID: 35257849 Free article. Review.
43 results